These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 21630121)

  • 1. Erlotinib and pancreatic adenocarcinoma: uncertainty and hope.
    Zoras O; Batsis C
    Ann Surg Oncol; 2011 Dec; 18 Suppl 3():S246-7. PubMed ID: 21630121
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in chemotherapy for pancreatic adenocarcinoma].
    Hammel P
    Gastroenterol Clin Biol; 2002; 26(6-7):603-4. PubMed ID: 12193859
    [No Abstract]   [Full Text] [Related]  

  • 3. Keys to personalized care in pancreatic oncology.
    Crane CH; Iacobuzio-Donahue CA
    J Clin Oncol; 2012 Nov; 30(33):4049-50. PubMed ID: 23045599
    [No Abstract]   [Full Text] [Related]  

  • 4. Perspectives in chemotherapy of pancreatic cancer.
    Klapdor R
    Eur J Surg Oncol; 1991 Apr; 17(2):153-66. PubMed ID: 1707835
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic advances in pancreatic cancer: miles to go before we sleep.
    Bekaii-Saab T; Goldberg R
    J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25638250
    [No Abstract]   [Full Text] [Related]  

  • 6. Response.
    Goldstein D; Von Hoff D
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26251330
    [No Abstract]   [Full Text] [Related]  

  • 7. Ifosfamide plus 5-fluorouracil for treatment of adenocarcinoma of the pancreas.
    Loehrer PJ; Williams SD; Nichols CR
    Cancer Treat Rep; 1987 Nov; 71(11):1115-6. PubMed ID: 3119208
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of preoperative chemotherapy on apoptosis and tissues of pancreatic adenocarcinoma].
    Liao Q; Zhao Y; Cai L; Chen J; Liu T; Zhu Y
    Zhonghua Wai Ke Za Zhi; 1999 Mar; 37(3):146-8, 7. PubMed ID: 11829805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of locally advanced pancreatic cancer with FOLFIRINOX].
    Strobel O; Büchler MW
    Chirurg; 2016 Aug; 87(8):699. PubMed ID: 27418266
    [No Abstract]   [Full Text] [Related]  

  • 10. Epirubicin plus a calmodulin inhibitor (trifluoperazine) activity in advanced pancreatic adenocarcinoma. T.T.D. Cooperative Spanish Group.
    Abad A; Masuti B; Camps C; Font A; Balañá C; Vicent JM; Sánchez JJ
    Eur J Cancer; 1994; 30A(7):1043. PubMed ID: 7946573
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemoimmunotherapy: still waiting for the magic to happen.
    Nowak AK; Lesterhuis WJ
    Lancet Oncol; 2014 Jul; 15(8):780-1. PubMed ID: 24954779
    [No Abstract]   [Full Text] [Related]  

  • 12. Tamoxifen or cyproterone acetate in combination with buserelin are ineffective in patients with pancreatic adenocarcinoma.
    Swarovsky B; Wolf M; Havemann K; Arnold R
    Oncology; 1993; 50(4):226-9. PubMed ID: 8497375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leuprolide and tamoxifen in the treatment of pancreatic cancer. A phase II study.
    Zaniboni A; Meriggi F; Arcangeli G; Alghisi A; Huscher C; Marini G
    Eur J Cancer; 1994; 30A(1):128. PubMed ID: 8142155
    [No Abstract]   [Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy in pancreatic cancer: innovative, but still difficult.
    Boeck S; Haas M; Ormanns S; Kruger S; Siveke JT; Heinemann V
    Br J Cancer; 2014 Oct; 111(8):1675-6. PubMed ID: 24642615
    [No Abstract]   [Full Text] [Related]  

  • 15. Pancreatic ductal adenocarcinoma: metastatic disease.
    Muñoz Martín AJ; Adeva J; Martínez-Galán J; Reina JJ; Hidalgo M
    Clin Transl Oncol; 2017 Dec; 19(12):1423-1429. PubMed ID: 28623515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic cancer: how can we progress?
    Casper ES
    Eur J Cancer; 1993; 29A(2):171-2. PubMed ID: 8422277
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chemotherapy in adenocarcinomas of the pancreas].
    Huguier M
    Gastroenterol Clin Biol; 2002 Nov; 26(11):1063; discussion 1063-4. PubMed ID: 12483149
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of metastatic pancreatic cancer: Current treatment options and potential new therapeutic targets.
    Sclafani F; Iyer R; Cunningham D; Starling N
    Crit Rev Oncol Hematol; 2015 Sep; 95(3):318-36. PubMed ID: 25921418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stellate cells, a point of light in the dark night of pancreatic cancer.
    Ramírez N; Viúdez A; Hernández-García I; Guerrero D; Gómez-Dorronsoro M; Herrera FJ; Vila J; Beloki L; Ciaúrriz M; Mansilla C; Vera R
    Br J Cancer; 2014 Oct; 111(8):1676-7. PubMed ID: 24642614
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase I dose escalation study of capecitabine and erlotinib concurrent with radiation in locally advanced pancreatic cancer.
    Jiang Y; Mackley HB; Kimchi ET; Zhu J; Gusani N; Kaifi J; Staveley-O'Carroll KF; Belani CP
    Cancer Chemother Pharmacol; 2014 Jul; 74(1):205-10. PubMed ID: 24908435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.